LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer

NCT04762901 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Funding was terminated.

Conditions

Breast Cancer

Interventions

DRUG: Niraparib
DRUG: Doxorubicin
DRUG: Cyclophosphamide
DRUG: Paclitaxel
DRUG: Pegfilgrastim
DRUG: Carboplatin

Sponsor

Wake Forest University Health Sciences

Collaborators

[object Object]